Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
MousePhenoincreased amino acid level

SLC7A9 PRODH

3.12e-047952MP:0014527
InteractionSLC39A1 interactions

CTLA4 PLEKHM2

1.54e-044882int:SLC39A1
InteractionB4GALT5 interactions

B4GALT6 CTLA4

2.41e-046082int:B4GALT5
ToppCelldroplet-Marrow-BM-30m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT6 CFAP47 PRODH

3.59e-06182838b16a13d8606d21a7a9ce1175237e9b4cf832ee0
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SLC7A9 CTLA4

2.85e-041458242dd36c1bc2c43cfea7196e89f901e4ea2a403c7
ToppCellMultiple_Sclerosis-Lymphocyte-T_NK-dnT|Multiple_Sclerosis / Disease, Lineage and Cell Type

CTLA4 PRODH

2.85e-0414582d24894be1d6664df9a6af8ea33f2ffce0c718635
ToppCell390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|390C / Donor, Lineage, Cell class and subclass (all cells)

SLC7A9 CTLA4

3.38e-0415882ad0e2371c0bc6e53d22518aa3a401cddcde3759f
ToppCellE18.5-Immune-Immune_Myeloid-DC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

B4GALT6 CFAP47

3.47e-04160829f1fec2cf565193c73cc3c8a4f0476e57478e3b8
ToppCellE18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

B4GALT6 CFAP47

3.56e-04162829333d923225df7bfdf6b3a4c32816751315aec50
ToppCellE18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

B4GALT6 CFAP47

3.56e-0416282388670cf3acef17df971c0d8ae3ce14398945192
ToppCell368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

SLC7A9 CTLA4

3.69e-04165823d2acdae0dd2b79a15f74158e8e566ce22b4218e
ToppCellPND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CFAP47 CTLA4

3.78e-0416782eed22d1a17aab84dacb1a488528bae9389644cb9
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CFAP47 CTLA4

3.82e-041688207be11b6f0f37106e219692db5795c6dd32807c9
ToppCellfacs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT6 PLEKHM2

3.82e-04168824ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1
ToppCellfacs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT6 PLEKHM2

3.82e-041688204e168fe1d6f5f9e3d3bf9d7c13e800e3594868a
ToppCellfacs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT6 PLEKHM2

3.87e-0416982454b92b9b67299a64278c010db033ca5b9d217a0
ToppCellPND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CFAP47 CTLA4

3.87e-0416982b08567ecfa3f8d83e7990330fc1b27f0bb7e75a1
ToppCellfacs-Marrow-Granulocytes-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT6 PRODH

3.96e-0417182dca4aa921896ec935fb7acdf25a62d8eba679602
ToppCell368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

SLC7A9 CTLA4

3.96e-0417182e59afa0a773dca3b9c208d17510ea55703b42598
ToppCellfacs-Marrow-Granulocytes-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT6 PRODH

3.96e-0417182add2f7d34889ec654b8c71b4b1f084736111dc88
ToppCellPrimary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CFAP47 PRODH

4.01e-041728255fba5ce0ead1114e1a76f67ad68432c6bac90e5
ToppCell3'_v3-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue

CFAP47 PRODH

4.01e-04172821b24bed3cd8e3fa463c5e7cefdf9e99e639e2f84
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CFAP47 PRODH

4.10e-041748253c2c132566a7682f3268c7f9138700f09c3b94d
ToppCellfacs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B4GALT6 PRODH

4.15e-0417582bb898796662b97f7459b7dda7cecf6a9bde8b055
ToppCellfacs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLEKHM2 PRODH

4.24e-04177822bf639e9e801e5144462ffc957f5739e0dfcd500
ToppCellfacs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLEKHM2 PRODH

4.24e-04177829c7c6824b9011363851f084a500d665f025b026e
ToppCellfacs-GAT-Fat-3m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 CFAP47

4.44e-041818211cb84528f7ca084f0a92eda4f2e18e63a428fe9
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CFAP47 PRODH

4.44e-041818246c428037b6eac605635e20e8cc78bce744b4daa
ToppCell5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Treg|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CTLA4 MFSD6

4.44e-04181823754970d62eea1d2522b11d977eea4362f90d21e
ToppCellfacs-GAT-Fat-3m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 CFAP47

4.44e-04181825ffeca29e4d31a20c110d27af128ed024a79ad56
ToppCellfacs-GAT-Fat-3m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 CFAP47

4.44e-0418182e97cbaafb93fdbee8e3cf4a06e6bcf121d941403
ToppCellHSPCs-Neutro_prog.|World / Lineage and Cell class

B4GALT6 PRODH

4.48e-0418282f2512354b90f55bf4172c28084bf52cf79e41d8a
ToppCelldroplet-Kidney-KIDNEY-30m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 PRODH

4.53e-041838292f54c267135cb5edbcacd26a0f29e62469bb7e5
ToppCelldroplet-Kidney-KIDNEY-30m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 PRODH

4.53e-04183825c4f7d02ba3a3c4a22ac71302e7c9a47e205eef5
ToppCelldroplet-Kidney-nan-18m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 PRODH

4.58e-0418482c86ed59fed687cdaaf7e9c4418d2e3e2c4111cca
ToppCelldroplet-Kidney-nan-21m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 PRODH

4.58e-04184823d7dd193a0826cc7a4e454a29236a16c315e5965
ToppCelldroplet-Kidney-nan-18m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 PRODH

4.58e-04184827c256bcfa07c5ff55aad0833e8712b0456b5832b
ToppCellPrimary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CFAP47 PRODH

4.58e-041848222c18964818fc9c8f18051f836d718937b0d8d12
ToppCelldroplet-Kidney-nan-21m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 PRODH

4.58e-041848245577ff91c3b2b303acd97239dde2463ea7a429c
ToppCelldroplet-Kidney-nan-3m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 PRODH

4.63e-04185820ff4148b4701003d9d594e0da8261176fb13aa59
ToppCelldroplet-Marrow-BM-1m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT6 PRODH

4.63e-04185823f1aa91efae2d00320d126087cce1431ad5f26ea
ToppCelldroplet-Kidney-nan-3m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 PRODH

4.63e-04185823e3217c99719fd1d2fa94e16be7712a7e5077152
ToppCelldroplet-Marrow-nan-21m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT6 PRODH

4.68e-0418682744bf39af2fb5a7454477174d7755a6d78cd279f
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CFAP47 PRODH

4.73e-04187822b1b2c3792d6c9ab69675ce88842bb589414b530
ToppCelldroplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 PRODH

4.73e-0418782236e9857729670e87eed30fad58f49e1f56e4a85
ToppCelldroplet-Marrow-nan-24m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT6 PRODH

4.73e-041878281d7c3802667190f11e9dcd797ee7b88aadbb8de
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CFAP47 PRODH

4.73e-0418782401be371b32066db926de3415bb4ce9465749dc3
ToppCellfacs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 PRODH

4.78e-0418882c1f64311ff05093b2f4f672e33f5f75e3bc8a8db
ToppCelldroplet-Marrow-nan-18m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT6 PRODH

4.78e-04188821b349618f77260564486586b7f5a47a77d12859c
ToppCellfacs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 PRODH

4.78e-0418882b483b4629695764568bcbd1d527d614824147783
ToppCelldroplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT6 PRODH

4.89e-0419082a1b5775a21d42633224b7d348f0d12b0589dad12
ToppCelldroplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT6 PRODH

4.89e-04190826f71a9f74af7cd9a674753cfc9833ebe5bba0fa2
ToppCell5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SLC7A9 PRODH

5.09e-0419482fcbf9c4f3801ab1a34fcd62c752fabc97fc7bde1
ToppCellBronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasmablast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CTLA4 THAP9

5.14e-0419582a045fb8a377e54fb57fef1181d4c3fc15d627ef6
ToppCellMacroglial-Astrocytes-GFAP---|Macroglial / cells hierarchy compared to all cells using T-Statistic

CFAP47 PRODH

5.41e-042008288d66550781a3c9102ff7455f5cff6fb072943cd
ToppCellBrain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type.

B4GALT6 PLEKHM2

5.41e-04200820927061536a664b4f7feb9e5b0a8c11ca0d5955c
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CFAP47 PRODH

5.41e-042008207d942803360e1a1e8e131d6e31c726dd0db1a0b
ToppCellMacroglial-Astrocytes-GFAP-|Macroglial / cells hierarchy compared to all cells using T-Statistic

CFAP47 PRODH

5.41e-0420082d6a059b0ef763c281c60b1ac76da6079ea822f80
ToppCellMacroglial-Astrocytes-GFAP--|Macroglial / cells hierarchy compared to all cells using T-Statistic

CFAP47 PRODH

5.41e-042008216269fa4adb28fc6ed032bbdba8781237dd0d249
ToppCellMacroglial-Astrocytes-GFAP|Macroglial / cells hierarchy compared to all cells using T-Statistic

CFAP47 PRODH

5.41e-042008279634b1086934412ae92f259ab43554ce545008f
ToppCellMacroglial-Astrocytes-GFAP----L1-2|Macroglial / cells hierarchy compared to all cells using T-Statistic

CFAP47 PRODH

5.41e-0420082c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f
DrugLoracarbef [121961-22-6]; Down 200; 10.8uM; PC3; HT_HG-U133A

B4GALT6 PLEKHM2 MFSD6

3.41e-05196835073_DN
DrugSuccinylsulfathiazole [116-43-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A

PLEKHM2 PRODH MFSD6

3.46e-05197832821_UP
DrugTheophylline monohydrate [5967-84-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A

B4GALT6 PLEKHM2 PRODH

3.51e-05198833326_DN
Drugpotassium iodide

B4GALT6 CTLA4

1.16e-044782CID000004875
Drugcitrullin

SLC7A9 PRODH

1.22e-0315382CID000000833
Drugparacrystals

CTLA4 MFSD6

1.35e-0316182CID000004685
DrugPimozide [2062-78-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A

CTLA4 THAP9

1.80e-03186823178_UP
Drugdl-ornithine

SLC7A9 PRODH

1.84e-0318882CID000000389
DrugRolipram [61413-54-5]; Up 200; 14.6uM; HL60; HT_HG-U133A

SLC7A9 THAP9

1.86e-03189823072_UP
Drug(+,-)-Synephrine [94-07-5]; Up 200; 24uM; HL60; HT_HG-U133A

SLC7A9 MFSD6

1.88e-03190826156_UP
Drugretinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A

PLEKHM2 PRODH

1.94e-03193826931_DN
DrugLithocholic acid [434-13-9]; Up 200; 10.6uM; PC3; HT_HG-U133A

B4GALT6 THAP9

1.96e-03194823816_UP
DrugIopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

1.96e-03194823527_DN
DrugSertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

1.96e-03194826811_DN
DrugTetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A

PLEKHM2 MFSD6

1.96e-03194826769_UP
DrugSisomicin sulfate [53179-09-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A

B4GALT6 PLEKHM2

1.96e-03194824132_DN
DrugMebendazole [31431-39-7]; Down 200; 13.6uM; PC3; HT_HG-U133A

PLEKHM2 MFSD6

1.96e-03194823671_DN
DrugTrihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; PC3; HT_HG-U133A

SLC7A9 PLEKHM2

1.98e-03195824015_DN
DrugDihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A

PRODH MFSD6

1.98e-03195822895_UP
DrugChlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HT_HG-U133A

CTLA4 THAP9

1.98e-03195826761_UP
DrugFursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A

PLEKHM2 PRODH

1.98e-03195824975_DN
Drugvalinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A

SLC7A9 B4GALT6

1.98e-03195825911_DN
Drug3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

1.98e-03195827361_UP
DrugApramycin [37321-09-8]; Down 200; 7.4uM; PC3; HT_HG-U133A

PLEKHM2 MFSD6

1.98e-03195826614_DN
DrugXylazine [7361-61-7]; Down 200; 18.2uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

1.98e-03195824147_DN
DrugClorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

2.00e-03196827025_UP
Drug6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

2.00e-03196827346_UP
DrugLevonordefrin [829-74-3]; Up 200; 21.8uM; MCF7; HT_HG-U133A

SLC7A9 PRODH

2.00e-03196827208_UP
DrugPicotamide monohydrate [80530-63-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A

SLC7A9 THAP9

2.00e-03196822233_UP
DrugEtofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A

B4GALT6 PLEKHM2

2.00e-03196824108_DN
Drugcarmustine; Up 200; 100uM; MCF7; HT_HG-U133A

PLEKHM2 MFSD6

2.00e-03196826888_UP
DrugEthaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A

SLC7A9 PRODH

2.00e-03196823375_UP
DrugXamoterol hemifumarate [73210-73-8]; Up 200; 5uM; HL60; HT_HG-U133A

SLC7A9 CTLA4

2.00e-03196823064_UP
DrugPralidoxime chloride [51-15-0]; Down 200; 23.2uM; HL60; HT_HG-U133A

B4GALT6 PLEKHM2

2.00e-03196823066_DN
DrugDoxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A

B4GALT6 PLEKHM2

2.02e-03197824988_DN
DrugStreptomycin sulfate [3810-74-0]; Up 200; 2.8uM; MCF7; HT_HG-U133A

B4GALT6 THAP9

2.02e-03197823195_UP
DrugNicergoline; Up 200; 8.2uM; PC3; HT_HG-U133A

B4GALT6 PRODH

2.02e-03197825775_UP
DrugHydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

2.02e-03197826011_DN
DrugPanthenol (D) [81-13-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A

SLC7A9 PRODH

2.02e-03197821680_UP
DrugMetyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A

B4GALT6 PLEKHM2

2.02e-03197824606_DN
DrugLomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

2.02e-03197824745_DN
DrugMonocrotaline [315-22-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A

PRODH THAP9

2.02e-03197822749_UP
DrugNapelline [5008-52-6]; Up 200; 11.2uM; HL60; HT_HG-U133A

B4GALT6 MFSD6

2.02e-03197822522_UP
DrugFlumequine [42835-25-6]; Up 200; 15.4uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

2.02e-03197825529_UP
DrugSulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A

B4GALT6 PLEKHM2

2.02e-03197822814_DN
DrugEpiandrosterone [481-29-8]; Up 200; 13.8uM; HL60; HT_HG-U133A

CTLA4 MFSD6

2.02e-03197822444_UP
DrugPyrilamine maleate [59-33-6]; Up 200; 10uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

2.02e-03197823184_UP
DrugFluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

2.02e-03197823370_DN
DrugFlecainide acetate [54143-56-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A

MFSD6 THAP9

2.02e-03197823937_UP
DrugPheniramine maleate [132-20-7]; Down 200; 11.2uM; MCF7; HT_HG-U133A

SLC7A9 PLEKHM2

2.02e-03197821492_DN
DrugMetronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A

SLC7A9 B4GALT6

2.04e-03198821503_DN
DrugLoxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A

SLC7A9 PRODH

2.04e-03198821516_UP
Drugfluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A

PLEKHM2 MFSD6

2.04e-03198821237_DN
DrugMethacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; HL60; HT_HG-U133A

MFSD6 THAP9

2.04e-03198822901_UP
DrugBergenin monohydrate [477-90-7]; Up 200; 11.6uM; PC3; HT_HG-U133A

SLC7A9 B4GALT6

2.04e-03198825870_UP
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA

B4GALT6 PRODH

2.04e-0319882983_DN
DrugICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A

PLEKHM2 MFSD6

2.04e-03198821238_DN
DrugVitamin K2 [11032-49-8]; Down 200; 9uM; MCF7; HT_HG-U133A

SLC7A9 B4GALT6

2.04e-03198823880_DN
DrugFipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; PC3; HT_HG-U133A

B4GALT6 PLEKHM2

2.04e-03198825737_DN
DrugDeptropine citrate [2169-75-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A

B4GALT6 PLEKHM2

2.04e-03198826523_DN
DrugFurosemide [54-31-9]; Up 200; 12uM; MCF7; HT_HG-U133A

B4GALT6 THAP9

2.04e-03198823197_UP
DrugUrapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; PC3; HT_HG-U133A

PLEKHM2 MFSD6

2.04e-03198826696_DN
DrugWY-14643; Up 200; 100uM; MCF7; HG-U133A

CTLA4 PLEKHM2

2.04e-0319882487_UP
DrugS(+)-Terguride [37686-84-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

2.04e-03198826459_DN
DrugTriamterene [396-01-0]; Up 200; 15.8uM; PC3; HT_HG-U133A

PLEKHM2 MFSD6

2.04e-03198827307_UP
DrugMetolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

2.04e-03198825392_DN
DrugAntipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; MCF7; HT_HG-U133A

SLC7A9 PLEKHM2

2.04e-03198824175_DN
DrugPentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A

SLC7A9 MFSD6

2.06e-03199825264_UP
DrugMolsidomine [25717-80-0]; Up 200; 16.6uM; PC3; HT_HG-U133A

SLC7A9 B4GALT6

2.06e-03199826325_UP
DrugPractolol [6673-35-4]; Down 200; 15uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

2.06e-03199825664_DN
DrugKetotifen fumarate [34580-14-8]; Up 200; 9.4uM; MCF7; HT_HG-U133A

B4GALT6 THAP9

2.06e-03199823200_UP
DrugClofilium tosylate [92953-10-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A

PLEKHM2 PRODH

2.06e-03199826830_DN
DrugMinocycline hydrochloride [13614-98-7]; Down 200; 8uM; MCF7; HT_HG-U133A

B4GALT6 PRODH

2.06e-03199827436_DN
DrugFlucytosine [2022-85-7]; Down 200; 31uM; HL60; HT_HG-U133A

B4GALT6 MFSD6

2.06e-03199823073_DN
DrugTrimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A

SLC7A9 PLEKHM2

2.06e-03199821502_DN
DrugMK-886; Down 200; 1uM; MCF7; HG-U133A

B4GALT6 CTLA4

2.06e-0319982264_DN
DrugZuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; HL60; HT_HG-U133A

MFSD6 THAP9

2.06e-03199822936_UP
DrugBenzocaine [94-09-7]; Up 200; 24.2uM; MCF7; HT_HG-U133A

B4GALT6 PLEKHM2

2.06e-03199822822_UP
DrugBenzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A

B4GALT6 THAP9

2.06e-03199823169_UP
DrugIsopropamide iodide [71-81-8]; Down 200; 8.4uM; PC3; HT_HG-U133A

B4GALT6 PLEKHM2

2.06e-03199827133_DN
DrugHomosalate [118-56-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A

SLC7A9 PRODH

2.06e-03199823879_DN
DrugAmiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A

SLC7A9 B4GALT6

2.06e-03199824119_DN
DrugAH6809; Up 200; 1uM; PC3; HT_HG-U133A

PLEKHM2 MFSD6

2.06e-03199827075_UP
DrugPrilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; MCF7; HT_HG-U133A

MFSD6 THAP9

2.06e-03199824749_UP
Drugmonastrol; Down 200; 100uM; MCF7; HG-U133A

B4GALT6 CTLA4

2.06e-0319982311_DN
Diseaseautoimmune disease

CTLA4 MFSD6

9.35e-0417382EFO_0005140
DiseaseThyroid preparation use measurement

CTLA4 MFSD6

1.46e-0321782EFO_0009933

Protein segments in the cluster

PeptideGeneStartEntry
YPLLPVYYKQLGMSP

MFSD6

86

Q6ZSS7
TYSPYLPCPEKLPYM

B4GALT6

101

Q9UBX8
EYPYLMEAYGPIPAY

SLC7A9

96

P82251
LYICKVELMYPPPYY

CTLA4

126

P16410
YPVLYLKCKPYQILY

CFAP47

2151

Q6ZTR5
DLAPYMPDYYKPQYL

PLEKHM2

161

Q8IWE5
YKYVPYGPVMEVLPY

PRODH

546

O43272
YVFPKVMPFPYLLTY

THAP9

591

Q9H5L6